Rafael Holdings, Inc. 13D and 13G filings for Cyclo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-10-24 4:43 pm Purchase |
2023-10-20 | 13D | Cyclo Therapeutics, Inc. CYTH |
Rafael Holdings Inc. RFL |
12,780,543 49.000% |
623,329 (+5.13%) |
Filing |
| 2023-08-07 3:35 pm Purchase |
2023-07-31 | 13D | Cyclo Therapeutics, Inc. CYTH |
Rafael Holdings Inc. RFL |
12,157,214 49.000% |
9,642,244 (+383.39%) |
Filing |
| 2023-05-11 4:48 pm Purchase |
2023-05-02 | 13D | Cyclo Therapeutics, Inc. CYTH |
Rafael Holdings Inc. RFL |
2,514,970 16.600% |
2,514,970 (New Position) |
Filing |